Key points are not available for this paper at this time.
produced potent dose-independent reduction of serum glucose levels, compared to the potent hypoglycemic drug gliclazide.
Al-Wahaibi et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: